Scientific findings on the effects of psilocybin truffle sessions

1. Letting go of the old identity and ego dissolution

Psychedelic substances such as psilocybin are known for a state of ego dissolution to be able to induce. Users often report that their usual sense of a separate “self” diminishes sharply or dissolves completely during the experience. This phenomenon – the temporary letting go of one’s own identity – is accompanied by a sense of unity with the environment and can bring about deep personal insights. Neuroscientific research links this ego dissolution to changes in brain activity: under the influence of psilocybin, activity and connectivity decrease in the default mode network (DMN), a brain network associated with self-reflection and sense of identity. For example, it has been observed that psilocybin acute hypoconnectivity caused between DMN core areas (such as the medial prefrontal cortex and posterior cingulate cortex), which correlates with the intensity of subjective ego loss. This shows that the “self”—possibly a brain-constructed cognitive bond—can temporarily dissolve under psilocybin.

Importantly, ego dissolution is not only a curiosity but is also associated with therapeutic breakthroughs. In a clinical study with depressed patients, the degree of “Oceanic Boundlessness” (a state of boundless unity and insight, closely related to ego dissolution) the strongest predictor of long-term symptom improvement. In other words: the more someone felt during the session that they were losing themselves in a state of connectedness and deep insights, the greater the lasting positive change afterward. This finding aligns with the hypothesis that psychedelics are therapeutically effective because they create a sense of affiliation recovering where there was once a rigid, isolated self-image. In summary, various studies support the idea that psilocybin truffle sessions can cause people to temporarily “let go” of their old identity—an ego dissolution that neurologically coincides with DMN repression and psychologically creates space for new perspectives on the self.

2. Reduction of anxiety, need for control, and worrying

There is growing scientific evidence that psilocybin can reduce anxiety symptoms and rigid control compulsion, both in clinical anxiety disorders (including obsessive-compulsive disorder) and in subclinical anxiety. A small-scale open-label study at OCD patients reported, for example, already significant reductions in compulsive symptoms: 24 hours after psilocybin intake, OCD scores (Y-BOCS) decreased by 23% to 100% compared to baseline. Notably, some participants were virtually symptom-free for up to a day after the session, well beyond the immediate duration of action of the drug. Although this concerned a first indication (9 patients), one patient maintained complete remission of OCD symptoms even after 6 months. This suggests that psilocybin—possibly through deep “transcending” experiences and rapid neurobiological effects—can alleviate OCD symptoms, something that is currently being further investigated in ongoing randomized studies.

Also at anxiety disorders and existential anxiety, promising results have been achieved. Two randomized double-blind studies from 2016 showed that a single high dose of psilocybin, supported by therapy, exceptionally strong and long-lasting reductions in anxiety and depression gave to cancer patients with existential anxiety. Most participants reported a drastic decrease in feelings of anxiety immediately after the session and even Six months later, ~80% of the patients had clinically significantly improved. in their anxiety and mood complaints (compared to the control condition). An anxiety-reducing effect is also observed in depressed patients without a life-threatening illness: a recent systematic review of RCTs in depression found that in 4 out of 5 studies, psilocybin significantly was better than the check in reducing comorbid anxiety symptoms. Furthermore, observational research among healthy users shows that psilocybin users remain affected for weeks to months after a session. scoring lower on general anxiety questionnaires. In a large-scale questionnaire study, average state and trait anxiety scores decreased significantly two weeks after the truffle experience, an effect that was still visible after 2–3 months. Notably, participants with more intense mystical experiences reported the strongest and most lasting anxiety reduction, suggesting that profound psychological experiences (such as experiences of oneness) are associated with more sustained anxiety reduction.

Neurobiologically speaking, there are clear correlates found that support this reduction in anxiety and worry. Psilocybin acts as an agonist on serotonin (5-HT)_2A receptors in the brain, which leads to, among other things, damping of limbic activity. For example, it has been demonstrated via fMRI that psilocybin acutely the amygdala reactivity reduces response to threatening stimuli. In one placebo-controlled study in healthy volunteers, psilocybin significantly reduced the amygdala response to negative emotional stimuli, which was accompanied by an increase in positive mood. This suggests that psilocybin turns down the biological “fear button,” as it were, which corresponds to less anxiety and rumination. Additionally, psilocybin reduces excessive activity and connectivity in brain regions involved in rumination and excessive control, such as the medial prefrontal cortex and anterior cingulate (core components of the default mode network and hyperactive in anxiety/OCD). By temporarily calming these networks, rumination and compulsive control mechanisms can be broken. It is also interesting that psilocybin in mice the extinction of fear conditionings accelerates and promotes the production of new neurons in the hippocampus – possible neurobiological explanations for the rapid decrease in avoidance behavior and anxiety after psychedelic therapy. In short, both clinical outcomes and neurobiological findings support that psilocybin helps to reduce pathological anxiety, compulsive control, and ruminating thoughts, both in the short term and – after integration – in the longer term.

3. Strengthening of feelings of love, trust, and inner security

A recurring finding in the literature is that psilocybin experiences strong positive emotions and feelings of connection can induce. During and after a truffle session, participants often report an increased feeling of love and connection – both for themselves (self-compassion, self-acceptance) and for others and the world around them. Quantitative studies confirm that psilocybin use is associated with improvements in interpersonal warmth and trust. In clinical settings, for example, researchers observed increased feelings of connectedness and acceptance in depressed patients after psilocybin therapy. A qualitative analysis of these patients described a transformation “from disconnection (of self, others, and the world) to connection” and from avoidance to acceptance. Afterward, patients felt more connected to loved ones and the world, and were open to more to trust in life and within oneself. Likewise, a study found that experiencing a full “mystical experience” under psilocybin was associated with increased gratitude, empathy and altruism afterwards – qualities indicating an increased loving and prosocial feeling towards oneself and others.

Such positive changes in feelings are also well documented in healthy volunteers. In several placebo-controlled studies in which psilocybin was administered in a supportive setting, the majority of subjects reported lasting positive changes in their emotional well-being and relationships. For example, the sense of increased among 60–90% of the participants well-being, life appreciation and self-acceptance after a single session significantly. Also striking were the social effects: participants indicated that they looked at others with a more positive attitude, felt more connected felt and could show trust and love more easily in relationships. Using standardized questionnaires, a significant increase in social connectedness measured, who was still present months after the session. Also self-compassion appears to improve: patients with depression, for example, showed a strong decrease in self-criticism and an increase in self-compassion after psilocybin therapy. This contributes to a sense of inner security – one feels more comfortable in one's own skin, with less anxiety and more security from within. Finally, the “positive mood” component Characteristic of a psilocybin experience (part of the mystical experience scale): people report intense feelings of joy, peace, and love during the peak of the trip. This emotional openness is often accompanied by trust: trust in the guides or the people around them, but also a renewed basic trust in life and within themselves. All these findings – from increased empathy and connectedness to more self-love and peace of mind – illustrate that psilocybin sessions have potential heart-opening experiences that can strengthen feelings of love, interpersonal trust, and inner security.

4. Development of intuition versus cognitive control

Various studies and reports indicate that psilocybin helps people to get less stuck in rigid, rational control mechanisms and to rely more on their intuition and inner compass. During such a psychedelic session, it often becomes clear how strongly someone normally tries to maintain control over thoughts and emotions – and how letting go of them can bring new insights. Qualitative interviews with treatment-resistant depression patients revealed that it ability to let go of control was a central factor for a successful experience. Patients who were able to “surrender” to the trip and trusted the process reported afterwards about spontaneous insights and a sense of to be guided by inner wisdom, in contrast to constantly analyzing or suppressing emotions. Conversely, the researchers observed that participants who continued to cling to their usual control (often driven by fear or perfectionism) benefited less and experienced difficult moments more frequently. These observations align with the principle of “trust, let go, be open” often emphasized in psychedelic therapy: letting go of cognitive control creates space for empathetic, intuitive experiences and emotional breakthroughs.

Neurologically, the loss of control under psilocybin can be traced back to the more flexible functioning of brain networks. Where our normal consciousness is dominated by top-down control (e.g., by the prefrontal cortex and the default mode network that drives the narrative self), psilocybin provides a more “entropic” brain state in which communication between different networks increases and fixed patterns temporarily fade. It has been shown, for example, that psilocybin and related substances the functional segregation breaking between brain networks and increasing global brain integration. This means that the brain thinks less in its usual, strictly controlled pathways, and rather associative and intuitive information processed. Subjectively, this state often translates into the experience of “noetic qualities”: the feeling of having access to a deeper knowledge or truth that has not been obtained through reasoning. In the classic definition of a mystical experience, this is described as a direct, intuitive insight into reality that feels inexpressible yet self-evident. Many psilocybin users indicate that during the session they sudden shifts in perspective and had insights (“aha experiences”) that were perceived as true and valuable, without having to take logical steps in their thinking. After integrating the experience, they subsequently report that they less inclined to over-analyze and dare to rely more on their feelings and values. For example, Watts et al. (2017) found that patients felt less “thought-trapped” after psilocybin therapy and instead a inner compass developed for what is meaningful and important in their lives.

Finally, therapists emphasize that strengthening intuition does not mean that rational thinking disappears, but that a healthier balance emerges. Psilocybin sessions often teach people that insights and decisions are not exclusively needing to get out of one's head. This is supported by clinical practice: patients show more after psychedelic therapy psychological flexibility and acceptance. They can observe thoughts and emotions without immediately intervening, and indicate relying more on spontaneous feelings and creative insights. In short, the literature suggests that psilocybin-assisted sessions the cognitive overcontrol can loosen, allowing a more intuitive, feeling-driven form of knowing and deciding to come to the forefront. Neurobiological findings (such as DMN attenuation and increased network plasticity) and qualitative participant reports both support the idea that psilocybin a shift from “thinking” to “feeling” facilitates – a renewed trust in the inner compass instead of exclusively in the analytical mind.

Sources: The mentioned findings are based on peer-reviewed studies, including clinical trials with psilocybin for various conditions, meta-analyses and systematic reviews, as well as qualitative studies into the subjective experiences of participants. Where relevant, neurobiological correlates from fMRI and other methods are also mentioned. neuroscientific studies (e.g., changes in DMN connectivity, amygdala reactivity, etc.) that support the psychological effects. This converging literature indicates that psilocybin truffle sessions have a unique therapeutic potential: they can temporarily “switch off” the ego, reduce anxiety and rumination, open the heart to love and connection, and reset the mind from rigid control to open intuition. In doing so, they offer scientifically substantiated starting points for the treatment of psychological problems as well as for positive personal growth under the guidance of professionals.